###begin article-title 0
###xml 0 26 0 26 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-gamma-Dependent Mechanism
###end article-title 0
###begin article-title 1
IL-32: An Emerging Player in the Immune Response Network against Tuberculosis?
###end article-title 1
###begin title 2
Background
###end title 2
###begin p 3
Interleukin (IL)-32 is a newly described proinflammatory cytokine that seems likely to play a role in inflammation and host defense. Little is known about the regulation of IL-32 production by primary cells of the immune system.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 530 556 526 552 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 561 569 557 565 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 919 934 915 930 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 1037 1052 1021 1036 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 530 556 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 561 573 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 919 934 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1037 1052 <span type="species:ncbi:1773">M. tuberculosis</span>
In the present study, freshly obtained human peripheral blood mononuclear cells were stimulated with different Toll-like receptor (TLR) agonists, and gene expression and synthesis of IL-32 was determined. We demonstrate that the TLR4 agonist lipopolysaccharide induces moderate (4-fold) production of IL-32, whereas agonists of TLR2, TLR3, TLR5, or TLR9, each of which strongly induced tumor necrosis factor alpha and IL-6, did not stimulate IL-32 production. However, the greatest amount of IL-32 was induced by the mycobacteria Mycobacterium tuberculosis and M. bovis BCG (20-fold over unstimulated cells). IL-32-induced synthesis by either lipopolysaccharide or mycobacteria remains entirely cell-associated in monocytes; moreover, steady-state mRNA levels are present in unstimulated monocytes without translation into IL-32 protein, similar to other cytokines lacking a signal peptide. IL-32 production induced by M. tuberculosis is dependent on endogenous interferon-gamma (IFNgamma); endogenous IFNgamma is, in turn, dependent on M. tuberculosis-induced IL-18 via caspase-1.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
In conclusion, IL-32 is a cell-associated proinflammatory cytokine, which is specifically stimulated by mycobacteria through a caspase-1- and IL-18-dependent production of IFNgamma.
###end p 7
###begin p 8
###xml 80 106 80 106 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 111 120 111 120 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis,</named-content>
###xml 80 106 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 111 119 <span type="species:ncbi:1765">M. bovis</span>
Synthesis of IL-32, a cell-associated proinflammatory cytokine, was promoted by Mycobacterium tuberculosis and M. bovis, suggesting a role in a role in inflammation and host defense against tuberculosis.
###end p 8
###begin title 9
Editors' Summary
###end title 9
###begin title 10

###end title 10
###begin title 11
Background.
###end title 11
###begin p 12
###xml 341 367 341 367 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 396 416 396 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis,</italic>
###xml 183 189 <span type="species:ncbi:9606">people</span>
###xml 282 288 <span type="species:ncbi:9606">humans</span>
###xml 341 367 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 396 415 <span type="species:ncbi:1765">Mycobacterium bovis</span>
###xml 430 436 <span type="species:ncbi:9913">cattle</span>
###xml 454 460 <span type="species:ncbi:9606">people</span>
Tuberculosis (TB) is a serious infectious disease that is becoming more common. Worldwide it causes around 2 million deaths every year, mostly in developing countries. Some 2 billion people-or one-third of the world's population-are chronically infected without active symptoms. In humans the disease is usually caused by a bacterium called Mycobacterium tuberculosis. Another related bacterium, Mycobacterium bovis, causes TB in cattle and sometimes in people.
###end p 12
###begin p 13
###xml 146 152 <span type="species:ncbi:9606">People</span>
The immune system, which defends the body against infections, involves a number of cells (for example, the white blood cells) and also chemicals. People with defects in their immune system are more likely to suffer from infectious diseases. Cytokines are one class of chemicals in the immune system. A particular cytokine called interleukin-32 (IL-32) has been shown to play a role in the development of inflammation, which is a part of the body's response to infection. Previous research has suggested that IL-32 might be of particular importance in the defenses against TB. In recent years scientists have discovered a lot about the processes involved in the "switching on" of the individual parts of the immune system in response to infection. However, very little is known about the factors influencing the switching on of production of IL-32.
###end p 13
###begin title 14
Why Was This Study Done?
###end title 14
###begin p 15
It would be useful to know more about the production of IL-32 because it would advance understanding of the immune system in general and, more specifically, how the body protects itself against bacteria, such as those that cause TB.
###end p 15
###begin title 16
What Did the Researchers Do and Find?
###end title 16
###begin p 17
###xml 756 771 756 771 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 776 784 776 784 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 756 771 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 776 784 <span type="species:ncbi:1765">M. bovis</span>
Working with eight healthy volunteers, the researchers took white blood cells of a particular type (peripheral blood mononuclear cells) and exposed them to substances known as TLR agonists. Toll-like receptors (TLRs) are receptors on the surface of leukocytes that recognize specific components of microorganisms. Upon recognition of these microbial components, which function as TLR stimuli (or TLR agonists), signals are transmitted that activate the immune system and thus the host defense. Using a complex series of laboratory procedures, they found that one type of TLR agonist (known as LPS) produced a big increase in IL-32 production, whereas all the other types of TLR agonists that they used produced only small increases. The researchers tested M. tuberculosis and M. bovis bacteria to see whether they increased IL-32 production and they found that they did so, to a greater degree even than LPS. The researchers also learned other details about IL-32 and the pathway of chemical changes that eventually leads to its production.
###end p 17
###begin title 18
What Do These Findings Mean?
###end title 18
###begin p 19
The researchers say their study provides several important insights into the biology of IL-32. The findings confirm that IL-32 is an important factor in the body's defenses against TB. This information will help in understanding how the disease spreads and who is most vulnerable to it. Ultimately, it may assist in the search for new ways of treating and preventing the disease.
###end p 19
###begin title 20
Additional Information.
###end title 20
###begin p 21
Please access these Web sites via the online version of this summary at .
###end p 21
###begin p 22
The online encyclopedia Wikpedia has useful information on
###end p 22
###begin p 23
Wikipedia also has useful information on the
###end p 23
###begin p 24
More detailed information about international efforts to control TB may be found at the Web sites of the  and the
###end p 24
###begin title 25
Introduction
###end title 25
###begin p 26
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b001">1</xref>
###xml 338 339 334 335 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sc>
###xml 361 362 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b001">1</xref>
###xml 470 471 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b002">2</xref>
Interleukin (IL)-32 is a recently described cytokine initially thought to be a product of T, natural killer, and epithelial cells. The cytokine exhibits several properties of a classical proinflammatory mediator [1]. For example, IL-32 induces the production of tumor necrosis factor (TNF) alpha, IL-8, and MIP-2 via the activation of NF-kB and p38 MAP kinase [1]. In addition, maturation of IL-1beta through a caspase-1-dependent mechanism is also a property of IL-32 [2]. These proinflammatory effects of IL-32 suggest an important role of IL-32 in inflammation and antibacterial defense.
###end p 26
###begin p 27
###xml 177 178 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b003">3</xref>
###xml 400 401 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b004">4</xref>
###xml 402 403 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b005">5</xref>
###xml 569 570 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b006">6</xref>
###xml 571 572 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b007">7</xref>
###xml 697 698 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b006">6</xref>
###xml 699 700 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b007">7</xref>
###xml 781 800 761 780 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium bovis</named-content>
###xml 956 957 932 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b008">8</xref>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
###xml 581 589 <span type="species:ncbi:9606">patients</span>
###xml 781 804 <span type="species:ncbi:33892">Mycobacterium bovis BCG</span>
###xml 834 842 <span type="species:ncbi:9606">patients</span>
###xml 946 954 <span type="species:ncbi:9606">patients</span>
In macrophages infected with intracellular pathogens, activation by interferon-gamma (IFNgamma) in combination with TNF is a major effector mechanism of cell-mediated immunity [3]. IFNgamma induces antimicrobial killing mechanisms in monocytes, macrophages, and neutrophils, by activating phagocytosis, stimulating oxygen radical production, and activating the synthesis of the inducible form of NO [4,5]. The crucial role of these IFNgamma properties for host antimicrobial defense has been demonstrated in patients with defects in either IFNgamma or IL-12 receptors [6,7]. These patients have increased susceptibility to intracellular microorganisms such as mycobacteria and salmonella species [6,7]. Infection with atypical mycbobacteria such as non-tuberculous mycobacteria or Mycobacterium bovis BCG is particularly dangerous in patients lacking adequate IFNgamma production and is a main factor determining the long-term prognosis of these patients [8].
###end p 27
###begin p 28
###xml 106 107 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b001">1</xref>
###xml 427 442 419 434 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 427 442 <span type="species:ncbi:1773">M. tuberculosis</span>
Because of the proinflammatory effects of IL-32 and its induction from epithelial cell lines by IFNgamma [1], we wanted to determine whether IL-32 is produced from primary cells of the immune system in response to stimulation with mycobacteria. We investigated the stimulation of IL-32 synthesis by several agonists of TLR, as well as bacterial pathogens. In the present study, we also define the IFNgamma-dependent pathway of M. tuberculosis-induced IL-32 from peripheral blood mononuclear cells (PBMCs).
###end p 28
###begin title 29
Methods
###end title 29
###begin title 30
Reagents and Microorganisms
###end title 30
###begin p 31
###xml 105 121 105 121 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Escherichia coli</named-content>
###xml 235 243 235 243 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 622 643 622 643 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Staphylococcus aureus</named-content>
###xml 714 715 714 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 718 719 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 105 121 <span type="species:ncbi:562">Escherichia coli</span>
###xml 235 247 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 622 643 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Synthetic Pam3Cys was purchased from EMC Microcollections (Tubingen, Germany). Lipopolysaccharide (LPS) (Escherichia coli serotype 055:B5) and poly I:C were purchased from Sigma Chemical (St. Louis, Missouri, United States). H37Rv and M. bovis BCG were grown to mid-log phase in Middlebrook 7H9 liquid medium supplemented with oleic acid, albumin, dextrose, and catalase (Difco Laboratories, Sparks, Maryland, United States), washed three times in sterile saline, and resuspended in RPMI 1640 medium. Separate culture suspensions were sonicated for 10 min on ice, in order to obtain noninfective cell lysates. Cultures of Staphylococcus aureus were grown in basic medium broth (Luria broth supplemented with 0.1% K2HPO4 and 0.1% glucose), washed in sterile saline, and resuspended in RPMI 1640 medium, as described above.
###end p 31
###begin title 32
Stimulation of Whole Blood Cultures with Mycobacteria
###end title 32
###begin p 33
###xml 193 208 192 207 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 193 208 <span type="species:ncbi:1773">M. tuberculosis</span>
After informed consent, venous blood was drawn from the antecubital vein of eight healthy volunteers into heparin tubes. Then 750 mul of either RPMI culture medium or RPMI containing sonicated M. tuberculosis or BGC (both at a concentration of 10 mug/ml) was added to 4.0-ml screw cap cryogenic tubes (Corning, Corning, New York, United States). Thereafter, 250 mul of freshly obtained heparinized blood was added to tubes containing stimuli. The tubes were capped tightly and incubated at 37 degreesC in an upright position. After 24 h of incubation, the blood was mixed by rapid vortex and transferred into 1.5-ml Eppendorf tubes (Brinkmann Instruments, Westbury, New York, United States). Triton X-100 (Bio-Rad Laboratories, Hercules, California, United States) was then added (0.5% final concentration) and the blood mixed until lysed. The lysed blood was stored at -70 degreesC until assay. In these whole blood cultures, intracellular and secreted cytokine concentrations were determined together, and the results represent "total" cytokine production.
###end p 33
###begin title 34
Isolation of PBMCs and Stimulation of Cytokine Production
###end title 34
###begin p 35
The PBMC fraction was obtained by density centrifugation of blood diluted 1:1 in pyrogen-free saline over Histopaque (Sigma, St. Louis, Missouri, United States). Cells were washed twice in saline and suspended in culture medium (RPMI 1640) supplemented with penicillin (100 U/ml) and streptomycin (100 mug/ml).
###end p 35
###begin p 36
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 256 263 251 258 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 290 291 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 333 358 328 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis, M. bovis</italic>
###xml 367 376 362 371 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 1139 1140 1125 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b009">9</xref>
###xml 1149 1164 1135 1150 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 256 263 <span type="species:ncbi:562">E. coli</span>
###xml 333 348 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 350 362 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 367 376 <span type="species:ncbi:1280">S. aureus</span>
###xml 1149 1164 <span type="species:ncbi:1773">M. tuberculosis</span>
To flat-bottom 96-well plates were added 5 x 105 PBMCs in a 100-mul volume, which was then incubated with either 100 mul of culture medium (negative control) or 100 mul of the various stimuli: synthetic Pam3Cys lipopeptide (5 mug/ml), poly I:C (5 mug/ml), E. coli LPS (100 ng/ml), or 1 x 107 heat-killed microorganisms/milliliter of M. tuberculosis, M. bovis BCG, or S. aureus. Each Toll-like receptor (TLR) ligand, except LPS, was checked for the presence of LPS in the LAL assay and found to be negative. After 24 h of incubation at 37 degreesC, supernatants were removed in some experiments. Otherwise, the cells were lysed by 1% Triton X-100 and two cycles of freeze-thaw. Intracellular and secreted cytokine concentrations were determined together, and the results represent "total" cytokine production. In additional experiments, the effect of a caspase-1 inhibitor (20 muM of Ac-Tyr-Val-Ala-Asp-2,6-dimethylbezoyloxymethylketone, YVAD, Alexis Biochemicals, San Diego, California, United States), IL-1 receptor antagonist (IL-1Ra, 10 mug/ml, R&D Systems, Minneapolis, Minnesota, United States), or IL-18 binding protein (10 mug/ml) [9] on the M. tuberculosis-induced production of IL-32 was investigated.
###end p 36
###begin p 37
In order to test whether the monocyte or lymphocyte population was the source of IL-32 after stimulation with mycobacteria, PBMCs were incubated for 2 h at 37 degreesC. The nonadherent cells, transferred into another well, were mostly lymphocytes, whereas the adherent cells were more than 90% monocytes. The stimulation of IL-32 by the mycobacteria was compared between monocytes and lymphocytes.
###end p 37
###begin p 38
###xml 528 543 528 543 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 547 555 547 555 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 225 230 <span type="species:ncbi:9606">human</span>
###xml 528 543 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 547 559 <span type="species:ncbi:33892">M. bovis BCG</span>
Production of IL-32 stimulated by mycobacteria was also investigated in monocyte-derived macrophages and dendritic cells (DCs). Adherent monocytes were incubated in RPMI for 5 d in the presence of either 20% heat-inactivated human serum for macrophage differentiation, or a combination of 50 ng/ml GM-CSF (Peprotech, Rocky Hill, New Jersey, United States) plus 20 ng/ml IL-4 (Peprotech) used for DC differentiation. After 5 d, the cells were washed, and the macrophages or DCs were stimulated for an additional 24 h with either M. tuberculosis or M. bovis BCG.
###end p 38
###begin title 39
Cytokine Measurements
###end title 39
###begin p 40
###xml 136 138 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b010">10</xref>
###xml 260 265 <span type="species:ncbi:9925">goats</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 778 783 <span type="species:ncbi:9606">human</span>
###xml 1533 1537 <span type="species:ncbi:9925">goat</span>
TNFalpha, IL-6, and IFNgamma concentrations were determined by specific electrochemiluminescence (ECL) assays, as previously described [10]. A specific ECL assay was developed for the measurement of IL-32. The IgG fraction of polyclonal antibodies produced in goats against recombinant human IL-32alpha was purified with Econo-Pac (Cooper, Boynton Beach, Florida, United States). This IgG fraction was then affinity purified using IL-32alpha immobilized on Affi-gel 15 agarose beads (Bio-Rad Laboratories). One aliquot of the affinity-purified anti-IL-32alpha antibody was labeled with biotin, and another aliquot with ruthenium according with the manufacturer's instructions (BioVeris, Gaithersburg, Maryland, United States). A standard curve was constructed using recombinant human IL-32alpha (Peprotech). For the assay, 25 mul of a sample or standard was added to 5-ml polypropylene tubes (Becton Dickinson, Franklin Lakes, New Jersey, United States) and incubated with dilutions of the biotinylated and the ruthenylated antibodies for a total aqueous phase of 100 mul and 25 mul of Dynabeads (BioVeris). After shaking at room temperature for 4 h, the reaction was terminated with 200 mul of phosphate-buffered saline (PBS). The electrochemiluminescent signal was measured using an Origen Analyzer (BioVeris), and the concentrations of IL-32 were calculated from the standard curve generated for each assay. In over ten assays, the ECL assay for IL-32 detected from 3 pg/ml to 2,000 pg/ml. Because of the polyclonal nature of the goat antibodies and the overlapping amino acids of the four IL-32 isoforms, all isoforms of IL-32 were likely detected in the ECL assay.
###end p 40
###begin title 41
RT-PCR for the IL-32 Isoforms
###end title 41
###begin p 42
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 117 132 117 132 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 374 376 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b011">11</xref>
###xml 894 901 888 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0030277-t001">Table 1</xref>
###xml 117 132 <span type="species:ncbi:1773">M. tuberculosis</span>
Ten million freshly isolated PBMCs were stimulated with either culture medium, 100 ng/ml LPS, or 1 x 107 heat-killed M. tuberculosis. After 4 h incubation at 37 degreesC, total RNA was extracted in 1 ml of TRIzol reagent (Invitrogen, Carlsbad, California, United States), an improved single-step RNA isolation method based on the method described by Chomczynski and Sacchi [11]. In addition, RNA was also isolated from an aliquot of freshly obtained PBMCs, without any culture or stimulation. Thereafter, RNA was precipitated with isopropanol, washed with 70% ethanol, and dissolved in water. Isolated RNA was treated with DNase before being reverse transcribed into complementary DNA using oligo(dT) primers and MMLV reverse transcriptase. PCR was performed using a Peltier Thermal Cycler-200 (Watertown, Massachusetts, United States). Primer sequences for the IL-32 isoforms are presented in Table 1: one set of primers detected both isoform alpha and beta, whereas two different sets of primers detected isoforms gamma and delta. GAPDH was used as a reference gene, for which the primers were 5'-GGC AAA TTC AAC GGC ACA-'3 (forward) and 5'-GTT AGT GGG GTC TCG CTC TG-'3 (reverse). PCR conditions were as follows: 2 min at 50 degreesC and 10 min at 95 degreesC, followed by 30 cycles of PCR reaction at 94 degreesC for 45 s, 70 degreesC for 2 min, and 59 degreesC for 1 min. The PCR products were run on 1% agarose gels stained with ethidium bromide.
###end p 42
###begin title 43
Immunostaining
###end title 43
###begin p 44
###xml 304 305 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 742 743 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 808 809 796 797 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 608 614 <span type="species:ncbi:9793">donkey</span>
###xml 705 710 <span type="species:ncbi:10090">mouse</span>
###xml 716 721 <span type="species:ncbi:9606">human</span>
###xml 799 804 <span type="species:ncbi:10090">mouse</span>
###xml 931 937 <span type="species:ncbi:9793">donkey</span>
###xml 943 948 <span type="species:ncbi:10090">mouse</span>
###xml 1006 1011 <span type="species:ncbi:4565">wheat</span>
Two distinct methods were used for immunostaining, confocal microscopy, and optical microscopy. For confocal microscopy, human PBMCs were isolated and cultured on eight-chamber glass slides (Nalge Nunc International, Naperville, Illinois, United States) at 37 degreesC in a humidified atmosphere of 5% CO2. After the cells were exposed to appropriate incubation conditions, they were fixed in 70% acetone and 30% methanol for 5 min and washed in PBS. Then the cells were fixed in 4% paraformaldehyde for 10 min at room temperature and washed with PBS. The fixed cells were permeabilized in PBS containing 5% donkey normal serum for 30 min at room temperature. This was followed by exposure to the primary mouse anti-human IL-32 monoclonal IgG1 antibody at 4 degreesC overnight. As negative control, mouse IgG1 was used instead of the anti-IL-32 antibody. After being washed in PBS, the cells were counterstained with the secondary donkey anti-mouse antibody linked to fluorescein-labeled Cy3 (1:150, red), wheat germ agglutinin (5 mug/ml, green for cell surface staining), and AMCA(33342) (50 mul/ml, blue) for 45 min at room temperature. Then the slides were mounted with aqueous antiquenching medium. The PBMCs were examined by digital deconvoluted microscopy.
###end p 44
###begin p 45
###xml 135 150 135 150 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 813 814 812 813 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 955 956 954 955 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 135 150 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 535 541 <span type="species:ncbi:9986">rabbit</span>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
###xml 804 809 <span type="species:ncbi:10090">mouse</span>
For optical microscopy, PBMCs were isolated and stimulated for 24 h in the presence of culture medium, LPS (100 ng/ml), or heat-killed M. tuberculosis (10 mug/ml) using TEFLON-PFA six-well format culture disks (Savillex, Minnetonka, Minnesota, United States) to avoid adherence of the PBMCs. After 24 h, cytospins of the stimulated cells were prepared and stained with the monoclonal anti-IL-32 antibody (MoAb, clone 9). The primary antibody (5 mg/ml) was diluted (1:500) and incubated for 30 min with the tissue sections, followed by rabbit anti-mouse HRPO (1:200, Dako, Glostrup, Denmark) for 60 min. The slides were then sequentially incubated with the chromogen (DAB) reagent for 10 min, counterstained with Mayer's hematoxylin, and mounted in permount. Negative control staining was performed using mouse IgG1 isotype antibody. A Leica (Wetzlar, Germany) microscope (DMRD model) equipped with a digital camera was used to prepare the microphotographs.
###end p 45
###begin title 46
Statistical Analysis
###end title 46
###begin p 47
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human experiments were performed in duplicate with blood obtained from eight volunteers. The differences between groups were analyzed by Mann-Whitney U test. The data are given as means +/- standard error of the mean (SEM).
###end p 47
###begin title 48
Results
###end title 48
###begin title 49
Stimulation of IL-32 by Mycobactyeria
###end title 49
###begin p 50
###xml 84 99 83 98 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 103 111 102 110 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 228 236 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g001">Figure 1</xref>
###xml 349 364 348 363 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 369 377 368 376 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 84 99 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 103 115 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 349 364 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 369 381 <span type="species:ncbi:33892">M. bovis BCG</span>
Whole blood diluted one in four with RPMI was stimulated with 10 mug/ml heat-killed M. tuberculosis or M. bovis BCG. After 24 h, there was significant stimulation of IL-32 as measured in the total cell lysate of these cultures (Figure 1A). The level of IL-32 in the lysates of whole blood cultures without stimulation was less than 5 pg/ml, whereas M. tuberculosis and M. bovis BCG increased total IL-32 synthesis over 30-fold.
###end p 50
###begin p 51
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g001">Figure 1</xref>
###xml 131 146 131 146 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 306 321 306 321 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 323 331 323 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g001">Figure 1</xref>
###xml 333 334 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 535 543 534 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g001">Figure 1</xref>
###xml 739 748 738 747 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 759 767 758 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g001">Figure 1</xref>
###xml 771 788 770 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans,</italic>
###xml 792 813 791 812 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Aspergillus fumigatus</named-content>
###xml 966 974 965 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g001">Figure 1</xref>
###xml 1047 1062 1046 1061 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 131 146 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 306 321 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 739 748 <span type="species:ncbi:1280">S. aureus</span>
###xml 771 787 <span type="species:ncbi:5476">Candida albicans</span>
###xml 792 813 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 1047 1062 <span type="species:ncbi:1773">M. tuberculosis</span>
As shown in Figure 1B, a dose-dependent stimulation of IL-32 release was observed when freshly isolated PBMCs were stimulated with M. tuberculosis. Interestingly, LPS also stimulated moderate amounts of IL-32 in PBMCs in a dose-dependent fashion, but these amounts were clearly lower than those induced by M. tuberculosis (Figure 1B). In contrast, stimulation with other TLR agonists such as Pam3Cys (TLR2) and poly I:C (TLR3) did not induce IL-32, despite incremental stimulations with concentrations of the stimuli up to 100 mug/ml (Figure 1C and data not shown). The TLR agonists flagellin (TLR5) and CpG (TLR9) did not induce IL-32 either (data not shown). Similarly, stimulation of PBMCs with other heat-killed microorganisms such as S. aureus (shown in Figure 1C), Candida albicans, or Aspergillus fumigatus (data not shown) did not stimulate IL-32 production. In contrast, all the TLR agonists and microorganisms described above were potent inducers of IL-6 (Figure 1D) and TNF (not shown) production, in ranges similar to those induced by M. tuberculosis or LPS.
###end p 51
###begin p 52
###xml 400 415 400 415 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 419 427 419 427 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 400 415 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 419 431 <span type="species:ncbi:33892">M. bovis BCG</span>
Unlike PBMC cultures, whole blood cultures contain all the plasma components including antibodies and macromolecules such as complement components and anti-proteases. Whereas PBMCs are composed of 10%-15% monocytes and mostly lymphocytes, whole blood cultures contain 60%-70% neutrophils, few monocytes (4%-6%), and about 20% lymphocytes. When comparing total IL-32 production stimulated with either M. tuberculosis or M. bovis BCG, whole blood cultures produced 136 pg per million monocytes, whereas in PBMC cultures, 420 pg were produced per million monocytes.
###end p 52
###begin title 53
IL-32 Induced by Inflammatory Stimuli Is a Cell-Associated Cytokine
###end title 53
###begin p 54
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 87 103 87 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis,</italic>
###xml 204 212 204 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g002">Figure 2</xref>
###xml 342 350 342 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g002">Figure 2</xref>
###xml 652 660 637 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g002">Figure 2</xref>
###xml 814 822 784 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g002">Figure 2</xref>
###xml 5 10 <span type="species:ncbi:9606">human</span>
###xml 87 102 <span type="species:ncbi:1773">M. tuberculosis</span>
When human PBMCs were stimulated with 1 x 107 microorganisms/milliliter of heat-killed M. tuberculosis, nearly all IL-32 measured was found in the cell-associated fraction and not the supernatant medium (Figure 2A). IL-32 was not detectable in freshly lysed PBMCs or in PBMCs incubated for 24 h without added stimulants. However, as shown in Figure 2B, steady-state levels of mRNA for IL-32beta, IL-32gamma, and IL-32delta are present in freshly isolated PBMCs without adherence to culture vessels. Levels of IL-32alpha are low but present. After 4 h of incubation with RPMI only, the levels of mRNA coding for each of the isoforms remained unchanged (Figure 2B). Upon stimulation with LPS for 24 h, there were markedly increased levels of IL-32alpha and IL-32gamma, but little change in IL-32beta and IL-32delta (Figure 2B).
###end p 54
###begin p 55
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g003">Figure 3</xref>
###xml 182 190 182 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g003">Figure 3</xref>
###xml 209 217 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g003">Figure 3</xref>
###xml 295 303 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g003">Figure 3</xref>
###xml 322 337 322 337 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 339 347 339 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g003">Figure 3</xref>
###xml 454 469 454 469 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 555 563 555 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g003">Figure 3</xref>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 322 337 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 454 469 <span type="species:ncbi:1773">M. tuberculosis</span>
As shown in Figure 3A, immunostaining with a monoclonal mouse anti-human IL-32 antibody also shows the absence of IL-32 protein in PBMC cultures after 24 h without added stimulants (Figure 3A, upper lane, and Figure 3B, left panel). However, IL-32 was present after 24 h of incubation with LPS (Figure 3A, middle lane) or M. tuberculosis (Figure 3A, lower lane). In addition, immunohistochemistry of the cytospins demonstrates that stimulation by LPS or M. tuberculosis revealed a pattern of IL-32 staining particularly associated with the cell membrane (Figure 3B, middle and right panels).
###end p 55
###begin title 56
Monocytes Are the Source of IL-32, but the Presence of Lymphocytes Increases IL-32 Production
###end title 56
###begin p 57
###xml 141 156 141 156 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 160 168 160 168 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 361 369 361 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g004">Figure 4</xref>
###xml 633 641 633 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g004">Figure 4</xref>
###xml 141 156 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 160 172 <span type="species:ncbi:33892">M. bovis BCG</span>
PBMCs were separated into adherent monocytes, and non-adherent lymphocytes, which were removed and cultured separately. When stimulated with M. tuberculosis or M. bovis BCG, monocytes were the primary source of IL-32, as demonstrated by the significantly higher concentration of IL-32 in the cell lysates of stimulated monocytes, compared with the lymphocytes (Figure 4A). However, comparison to the mixture of monocytes and lymphocytes in unfractionated PBMCs makes it clear that the presence of lymphocytes potentiates the stimulation of IL-32 by the monocytes, and thus contributes significantly to the total production of IL-32 (Figure 4A). Each volunteer tested in the present study was PPD-negative, which rules out the influence of lymphocytes due to antigen presentation of mycobacteria to specific T cells.
###end p 57
###begin p 58
###xml 245 253 245 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g004">Figure 4</xref>
###xml 385 393 385 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g004">Figure 4</xref>
###xml 424 439 424 439 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 444 452 444 452 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 124 129 <span type="species:ncbi:9606">human</span>
###xml 424 439 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 444 456 <span type="species:ncbi:33892">M. bovis BCG</span>
To investigate the production of IL-32 by differentiated monocytes, freshly obtained blood monocytes were cultured with 20% human serum to induce macrophage-like cells, or with a combination of GM-CSF/IL-4 to obtain a DC population. As shown in Figure 4B, monocyte-derived macrophages and DCs produced approximately the same amount of IL-32 as freshly cultured adherent monocytes (see Figure 4A). This was observed for both M. tuberculosis and M. bovis BCG stimulation.
###end p 58
###begin title 59
IFNgamma Induces Production of IL-32 in Primary Cells
###end title 59
###begin p 60
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g005">Figure 5</xref>
###xml 269 270 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b001">1</xref>
As shown in Figure 5, PBMCs stimulated with IFNgamma induced an 8-fold increase in IL-32. In contrast, IL-1beta or TNFalpha did not stimulate the production of IL-32 in PBMCs, although these cytokines (similar to IFNgamma) are able to induce IL-32 in epithelial cells [1]. As a control, in the same PBMC cultures IL-1beta and TNFalpha induced chemokines and IL-6, whereas IFNgamma did not (data not shown). Therefore, it appears that IFNgamma is a highly selective IL-32-inducing cytokine for blood monocytes.
###end p 60
###begin p 61
###xml 178 193 170 185 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 218 226 208 216 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 284 293 270 279 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 319 330 303 314 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">C. albicans</named-content>
###xml 178 193 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 218 230 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 284 293 <span type="species:ncbi:1280">S. aureus</span>
###xml 319 330 <span type="species:ncbi:5476">C. albicans</span>
We have compared the production of IFNgamma induced by the various stimuli used for the induction of IL-32 release. The highest amounts of IFNgamma production were stimulated by M. tuberculosis (987 +/- 185 pg/ml) and M. bovis BCG (794 +/- 201 pg/ml), whereas LPS (217 +/- 44 pg/ml), S. aureus (343 +/- 101 pg/ml), and C. albicans (197 +/- 88 pg/ml) induced moderate amounts of the cytokine. No IFNgamma production was induced by Pam3Cys or poly I:C (data not shown). These data suggest that the induction of IL-32 by mycobacteria and LPS may be at least in part mediated by endogenous IFNgamma release.
###end p 61
###begin p 62
###xml 43 57 43 57 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. epidermidis</named-content>
###xml 186 188 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b012">12</xref>
###xml 316 318 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b013">13</xref>
###xml 319 321 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b014">14</xref>
###xml 336 344 324 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g005">Figure 5</xref>
###xml 347 362 335 350 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 559 567 539 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g005">Figure 5</xref>
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 43 57 <span type="species:ncbi:1282">S. epidermidis</span>
###xml 347 362 <span type="species:ncbi:1773">M. tuberculosis</span>
In human PBMCs stimulated with heat-killed S. epidermidis or LPS, IFNgamma production is dependent on IL-18, since in the presence of IL-18BP IFNgamma production is reduced by over 80% [12]. The role of IL-18 in IFNgamma production by microbial products is dependent on processing and release of IL-18 by caspase-1 [13,14]. As shown in Figure 5B, M. tuberculosis-induced IFNgamma production was reduced 80% by the neutralization of endogenous IL-18 by IL-18BP. In contrast, the production of TNFalpha was unaffected by the neutralization of endogenous IL-18 (Figure 5B).
###end p 62
###begin title 63
###xml 0 15 0 15 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
M. tuberculosis Stimulates IL-32 through a Caspase-1/IL-18/IFNgamma-Dependent Mechanism
###end title 63
###begin p 64
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g006">Figure 6</xref>
###xml 72 87 72 87 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 422 437 411 426 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 526 534 515 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g006">Figure 6</xref>
###xml 710 711 691 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 865 873 838 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g006">Figure 6</xref>
###xml 946 954 915 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g005">Figure 5</xref>
###xml 1160 1175 1113 1128 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 1235 1243 1188 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g006">Figure 6</xref>
###xml 1400 1408 1345 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g006">Figure 6</xref>
###xml 1461 1476 1406 1421 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 72 87 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 422 437 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1160 1175 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1461 1476 <span type="species:ncbi:1773">M. tuberculosis</span>
As shown in Figure 6A, the production of IL-32 in PBMCs stimulated with M. tuberculosis was reduced by 83% in the presence of the caspase-1 inhibitor. Under these same conditions IFNgamma levels were reduced by 77%, but TNFalpha production was unaffected by the inhibition of caspase-1. To determine whether inhibition of caspase-1 was reducing the activity of endogenous IL-18 or IL-1beta, the PBMCs were stimulated with M. tuberculosis in the presence of their respective natural inhibitors, IL-18BP and IL-1Ra. As shown in Figure 6C, blocking IL-1 activity with saturating concentrations of IL-1Ra had no effect on the production of IL-32, IFNgamma, or TNFalpha, whereas IL-6 production was reduced by 44% (p < 0.05; data not shown). As expected, in these same cultures, IL-18BP reduced both IL-32 (92% reduction) and IFNgamma (88% reduction), but not TNFalpha (Figure 6B). Although we observed that exogenous IFNgamma induced IL-32 in PBMCs (Figure 5A), in order to assess whether endogenous IFNgamma provided a similar signal, IFNgamma activity was neutralized with neutralizing anti-IFNgamma antibody. Blockade of endogenous IFNgamma activity induced by M. tuberculosis strongly inhibited the production of IL-32 (56% reduction; Figure 6D). Not unexpectedly, reducing IFNgamma activity also moderately reduced TNFalpha synthesis, although this reduction did not reach statistical significance (Figure 6D). Collectively, these experiments demonstrate that M. tuberculosis stimulates the production of IL-32 through a caspase-1/IL-18/IFNgamma pathway.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 70 85 70 85 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 89 97 89 97 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 385 400 385 400 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 607 622 599 614 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 627 635 619 627 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 1092 1107 1076 1091 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 70 85 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 89 101 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 385 400 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 607 622 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 627 639 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 1092 1107 <span type="species:ncbi:1773">M. tuberculosis</span>
In the present study we demonstrate that mycobacteria species such as M. tuberculosis or M. bovis BCG are potent stimuli for the production of the newly described proinflammatory cytokine IL-32. Steady-state levels of mRNA for IL-32 were present in freshly obtained blood PBMCs in the absence of culture or stimulants in healthy individuals, but also after 24 h of incubation. LPS and M. tuberculosis increased steady-state levels of IL-32 mRNA for isoforms alpha and gamma of the cytokine. Although the ability of LPS to induce the synthesis of IL-32 was moderate (3- to 4-fold increase), the mycobacteria M. tuberculosis and M. bovis BCG induced up to a 20-fold increase in IL-32 synthesis over PBMCs cultured in the absence of mycobacteria. Furthermore, we demonstrated that the increase in IL-32 production by mycobacteria is dependent of the proinflammatory pathway involving active IL-18 induced by a caspase-1-dependent pathway. However, the role for IL-18 is primarily the production of IFNgamma, which in turn stimulates IL-32. Indeed, neutralization of endogenous IFNgamma prevents M. tuberculosis-induced IL-32, and culturing PBMCs with exogenous IFNgamma increases IL-32 production 10-fold. We conclude that IFNgamma is the ultimate mediator of IL-32 synthesis induced by mycobacteria.
###end p 66
###begin p 67
###xml 213 221 213 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g001">Figure 1</xref>
###xml 861 862 853 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b006">6</xref>
###xml 863 864 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b008">8</xref>
###xml 1222 1223 1210 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b002">2</xref>
###xml 1403 1405 1391 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b015">15</xref>
When PBMCs were stimulated with a large variety of TLR agonists and heat-killed microorganisms, mycobacteria were the most potent in inducing the synthesis of IL-32 in both whole blood and freshly isolated PBMCs (Figure 1). Of the TLR agonists, only the TLR4 stimulus LPS was able to stimulate moderate production of IL-32 (3- to 4-fold increase). These data suggest that while LPS/TLR4 interaction can increase transcription of IL-32 mRNA over that present in unstimulated cells, a second signal for synthesis is provided specifically by mycobacteria for the production of the protein. The specificity of IL-32 stimulation by mycobacteria, but not other microorganisms, is clinically significant since IL-32 is an IFNgamma-inducible gene, and IFNgamma pathway defects are accompanied by an increased susceptibility to infection with low-virulent mycobacteria [6-8]. This specificity suggests a potential role of IFNgamma-induced IL-32 in the host defense against mycobacterial infections. The findings are also suggestive of a role of IL-32 in mediating some of the consequences of mycobacterial stimulation. For example, we have reported that IL-32 synergizes specifically with the muramyldipeptide for IL-6 production [2]. The muramyldipeptide is the minimal structure able to reproduce the adjuvant properties of the mycobacterial cell wall, and IL-6 plays a central role in this adjuvant activity [15].
###end p 67
###begin p 68
###xml 44 45 40 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b001">1</xref>
###xml 199 200 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b001">1</xref>
###xml 235 243 228 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g004">Figure 4</xref>
###xml 294 309 287 302 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 635 637 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b016">16</xref>
###xml 667 682 648 663 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 745 753 726 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0030277-g004">Figure 4</xref>
###xml 810 812 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b017">17</xref>
###xml 974 989 951 966 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 1242 1258 1213 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis&#8211;</italic>
###xml 1319 1334 1290 1305 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 1547 1562 1510 1525 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 294 309 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 667 682 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 974 989 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1242 1257 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1319 1334 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1547 1562 <span type="species:ncbi:1773">M. tuberculosis</span>
IFNgamma induces IL-32 in epithelial cells [1], and we have observed a similar induction in PBMCs. Although other proinflammatory cytokines such as TNF and IL-1beta induce IL-32 in epithelial cells [1], this was not observed in PBMCs (Figure 4). We investigated whether stimulation of IL-32 by M. tuberculosis is indeed mediated through synthesis of endogenous IFNgamma. Although the monocyte is the primary source of IL-32, lymphocytes are also required for optimal IL-32 synthesis. It is well established that lymphocytes and natural killer cells are the two main cell populations involved in the production and release of IFNgamma [16]. Stimulation of IFNgamma by M. tuberculosis was dependent on intermediary production of endogenous IL-18 (Figure 4), similarly to the stimulation by other microorganisms [17]. Inhibition of IL-18 processing by caspase-1, or neutralization of IL-18 by IL-18BP, inhibited not only IFNgamma production, but also the induction of IL-32 by M. tuberculosis. Because caspase-1 also inhibits processing of pro-IL-1beta into an active mature form, it was necessary to exclude a role for endogenous IL-1beta in the effects of the caspase-1 inhibitor. Unlike for IL-18, blockade of IL-1 by IL-1Ra had no effect on M. tuberculosis-induced IL-32 production. The fact that IL-32 stimulation by M. tuberculosis was mediated by the release of endogenous IFNgamma was further demonstrated by the blockade of IL-32 synthesis by a neutralizing antibody to IFNgamma. Thus, the chain of events leading to stimulation of IL-32 by M. tuberculosis involves caspase-1-dependent IL-18 from monocytes, which stimulates production of IFNgamma from lymphocytes. IFNgamma, in turn, drives the translational machinery for IL-32 synthesis in the monocytes and macrophages.
###end p 68
###begin p 69
###xml 336 352 313 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis,</italic>
###xml 336 351 <span type="species:ncbi:1773">M. tuberculosis</span>
Steady-state levels of mRNA coding for IL-32beta, IL-32gamma, and IL-32delta are clearly present in freshly obtained PBMCs, whereas gene expression for IL-32alpha is barely detectable; importantly, there is no detectable IL-32 protein in the lysates of these cells. IL-32 mRNA of isoforms alpha and gamma was stimulated by both LPS and M. tuberculosis, while isoform beta was quite strongly expressed in steady-state unstimulated cells, and was not further induced by stimulation. In contrast, IL-32 mRNA isoform delta expression was heterogenous, both in terms of basal steady-state expression and response to stimulation. Even after 24 h of culture on a plastic surface, there was no IL-32 protein in the lysates. However, upon stimulation with LPS and mycobacteria, IL-32 protein concentration rose 4-fold and 20-fold, respectively. Since the ECL method for detecting IL-32 does not distinguish between the different isoforms, the IL-32 protein in the lysates could be due to any one of the isoforms.
###end p 69
###begin p 70
###xml 398 400 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b018">18</xref>
###xml 561 563 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b019">19</xref>
###xml 658 660 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b019">19</xref>
###xml 789 791 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b020">20</xref>
###xml 864 866 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b020">20</xref>
###xml 1126 1128 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b020">20</xref>
###xml 1254 1256 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b019">19</xref>
###xml 1920 1929 1862 1871 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 1933 1944 1875 1886 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">C. albicans</named-content>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 1920 1929 <span type="species:ncbi:1280">S. aureus</span>
###xml 1933 1944 <span type="species:ncbi:5476">C. albicans</span>
The dissociated expression of the IL-32 gene and synthesis of the cytokine itself is reminiscent of the dissociation of IL-1beta gene expression and synthesis in PBMCs. In studies of IL-1beta expression, adherence to glass or plastic in the strict absence of endotoxins or other microbial agents was sufficient for IL-1beta gene expression, but not for the translation into the IL-1beta precursor [18]. Even using the inflammatory C5a complement component, human PBMCs exhibit the same levels of IL-1beta and TNFalpha gene expression as those induced with LPS [19] but, in the case of C5a stimulation, without detectable translation of IL-1beta or TNFalpha [19]. In those studies, there was no failure of mRNA coding of IL-1beta to associate with large polysomes and initiate translation [20]; in fact, evidence revealed that initiation of translation was intact [20]. However, adherence to glass and plastic surfaces or stimulation by C5a was not sufficient to complete the translation into the IL-1beta precursor. The failure to complete translation appeared to be due to early termination of elongation of the polypeptide [20]. LPS or IL-1beta itself at exceedingly low concentrations provide the intracellular components to complete the translation [19]. It is presently unknown whether mRNA coding for IL-32alpha, IL-32beta, IL-32gamma, or IL-32delta is similarly incapable of completing translation or whether binding to the ribosome is defective. However, the data in the present study suggest that unlike most mRNA coding for cytokines, IL-32 mRNA belongs to the class of proinflammatory cytokines that are regulated unless a second signal is provided. In addition, stronger IFNgamma stimulation by mycobacteria compared to other stimuli could also have played a role in the differential stimulation of IL-32. However, IFNgamma and IL-32 production were not completely correlated, as some microorganisms such as S. aureus or C. albicans induced IFNgamma production, yet they were incapable of stimulating IL-32 release. In this respect, the release of intermediary IFNgamma seems to be a necessary, but not sufficient, step in the induction of IL-32.
###end p 70
###begin p 71
###xml 509 524 505 520 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 797 799 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b021">21</xref>
###xml 905 920 894 909 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 1039 1041 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b022">22</xref>
###xml 1042 1044 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b023">23</xref>
###xml 151 156 <span type="species:ncbi:9606">human</span>
###xml 251 255 <span type="species:ncbi:9925">goat</span>
###xml 261 266 <span type="species:ncbi:9606">human</span>
###xml 509 524 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 905 920 <span type="species:ncbi:1773">M. tuberculosis</span>
Corroborating these findings is the absence of IL-32 protein in adherent blood monocytes cultured for 24 h and examined by immunostaining with an anti-human IL-32 monoclonal antibody. The absence of IL-32 protein employing either an affinity-purified goat anti-human IL-32alpha antibody or the monoclonal antibody supports the concept that IL-32 gene expression can exist without translation into IL-32 protein. The monoclonal antibody's ability to detect IL-32 was apparent following stimulation with LPS or M. tuberculosis. There was staining for IL-32 on the cells' surface and measurable IL-32 in the lysates of these cells. The staining of IL-32 in the confocal microscopy was comparable to the diffuse cytosolic staining patterns seen for IL-1alpha and IL-1beta in LPS-stimulated monocytes [21]. However, the localized immunohistochemical staining of the cell membrane after stimulation with LPS or M. tuberculosis suggests that IL-32 is a cell-associated cytokine, similar to other cytokines such as IL-1alpha or lymphotoxin-alpha [22,23].
###end p 71
###begin p 72
###xml 270 285 267 282 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 270 285 <span type="species:ncbi:1773">M. tuberculosis</span>
Both IL-32 (all isoforms) and IL-1beta lack a classic signal peptide. Therefore, it is not unexpected that in stimulated blood monocytes there is no detectable IL-32 in the supernatant whereas the cell lysates contain nearly all of the measurable IL-32. Because LPS and M. tuberculosis stimulate caspase-1 cleavage of IL-1beta, the lack of secreted IL-32 is consistent with the absence of a caspase-1 site in any of the isoforms of IL-32. In fact, the decrease in IL-32 synthesis in the presence of a caspase-1 inhibitor is not a direct effect of caspase-1 on IL-32 but rather on IL-18-induced IFNgamma production. In addition, there is no structural relationship between members of the IL-1 family and IL-32, also supporting the absence of caspase-1 cleavage sites in IL-32.
###end p 72
###begin p 73
###xml 587 589 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b024">24</xref>
###xml 694 706 668 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. albicans,</italic>
###xml 1000 1002 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b025">25</xref>
###xml 1206 1208 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b026">26</xref>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 694 705 <span type="species:ncbi:5476">C. albicans</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
Several cytokines and growth factors lack a clear signal peptide and are not secreted, but nevertheless play a role in the pathogenesis of disease. For example, IL-1alpha is not secreted from monocytes following stimulation by LPS and other TLR agonists, despite the presence of large intracellular stores. Yet, IL-1alpha plays an important role in immune responses to specific antigens. Comparing mice deficient in IL-1alpha or IL-1beta, IL-1alpha but not IL-1beta was required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity [24]. In addition, macrophages of mice deficient in IL-1alpha display defective phagocytosis and killing of C. albicans, which contributes to their increased susceptibility to disseminated infections in these mice (A. G. Vonk, M. G. Netea, J. H. van Krieken, Y. Iwakura, J. W. van der Meer, et al., unpublished data). Similarly, membrane-bound TNFalpha plays an important role in the pathogenesis of tuberculosis [25]. Another cytokine, acidic fibroblast growth factor also lacks a signal peptide and is found primarily in the cytosol. Yet, acidic fibroblast growth factor plays an important role in neural cell growth [26]. Similarly, although IL-32 appears to be mainly a cell-associated cytokine, its proinflammatory properties suggest important effects on inflammation and host defense.
###end p 73
###begin p 74
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0030277-b027">27</xref>
###xml 510 525 510 525 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 530 538 530 538 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 510 525 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 530 542 <span type="species:ncbi:33892">M. bovis BCG</span>
An important issue relevant to the present study is the identity of the pattern-recognition receptors that trigger the translation the of IL-32 mRNA following stimulation with mycobacteria. The induction of IL-32 by LPS suggests that TLR4 may be involved, and this is consistent with the studies showing a role of TLR4 in the recognition of mycobacteria [27]. However, TLR4 alone is unlikely to be the sole pathway needed for IL-32 stimulation, given the less efficient induction of IL-32 by LPS compared with M. tuberculosis and M. bovis BCG. It is therefore likely that a secondary pathway is activated by mycobacteria, which is needed in combination with TLR4 stimulation for the induction of IL-32. Further studies are needed to elucidate this aspect.
###end p 74
###begin p 75
###xml 237 246 237 246 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 272 283 272 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. albicans</italic>
###xml 288 300 288 300 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">A. fumigatus</named-content>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 237 246 <span type="species:ncbi:1280">S. aureus</span>
###xml 272 283 <span type="species:ncbi:5476">C. albicans</span>
###xml 288 300 <span type="species:ncbi:5085">A. fumigatus</span>
In conclusion, the results of the present study give several important insights into the biology of IL-32. Firstly, mycobacteria species induce production of IL-32 from human monocytes and macrophages, while other microorganisms such as S. aureus and the fungal pathogens C. albicans and A. fumigatus do not. Secondly, this capacity of mycobacteria to stimulate IL-32 is mediated by their capacity to induce IFNgamma, a crucial cytokine of host defense against these microorganisms. Furthermore, IL-32 is a cell-associated cytokine, and in this form may exert its proinflammatory effects.
###end p 75
###begin title 76

###end title 76
###begin p 77
We thank BioVeris Corporation for assistance with the ECL assays described in this study.
###end p 77
###begin p 78
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author Contributions.</bold>
Author Contributions. MGN, DL, TO, SHK, and CAD designed the study. TA, ECL, LABJ, MW, DL, and XM collected data or did experiments for the study. TA helped generate recombinant IL-32. LABJ participated in IL-32 expression of PBMCs after exposure to LPS and MTB. MW participated in the immunocytochemistry for IL-32 staining in PBMCs treated with different stimuli and took the picture. DL provided the necessary mycobacterial stimulating components and help in using them in the experiments. DYY prepared anti-IL-32 antibodies. CAD developed the assays also. EDC participated in intellectual input and discussions with MGN. MGN, XM, TO, SHK, and CAD analyzed the data. MGN, EDC, TO, and CAD contributed to writing the paper.
###end p 78
###begin p 79
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: The study was supported by the National Institutes of Health grants AI-15614, HL-68743, and CA046934 to CAD. MGN was supported by a Vidi grant of the Netherlands Organization for Scientific Research (NWO-ZonMW). DL was supported by grants from NWO-ZonMW, the Netherlands Leprosy Relief Foundation, and the Royal Netherlands Academy of Arts and Sciences. SHK was supported by grant R01-2006-000-10837 from the Korean Science and Engineering Foundation and by the faculty research fund of Konkuk University in 2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 79
###begin p 80
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 80
###begin title 81
Abbreviations
###end title 81
###begin p 82
dendritic cell
###end p 82
###begin p 83
electrochemiluminescence
###end p 83
###begin p 84
interleukin
###end p 84
###begin p 85
interferon-gamma
###end p 85
###begin p 86
lipopolysaccharide
###end p 86
###begin p 87
peripheral blood mononuclear cell
###end p 87
###begin p 88
phosphate-buffered saline
###end p 88
###begin p 89
standard error of the mean
###end p 89
###begin p 90
Toll-like receptor
###end p 90
###begin p 91
tumor necrosis factor
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
Interleukin-32: A cytokine and inducer of TNF-alpha
###end article-title 93
###begin article-title 94
IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism
###end article-title 94
###begin article-title 95
###xml 11 16 <span type="species:ncbi:9606">human</span>
Control of human host immunity to mycobacteria
###end article-title 95
###begin article-title 96
###xml 35 40 <span type="species:ncbi:9606">human</span>
In vitro and in vivo activation of human mononuclear phagocytes by interferon-g
###end article-title 96
###begin article-title 97
###xml 52 57 <span type="species:ncbi:9606">human</span>
Immune interferon enhances functional properties of human granulocytes: Role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor
###end article-title 97
###begin article-title 98
###xml 24 29 <span type="species:ncbi:9606">human</span>
Genetics, cytokines and human infectious disease: Lessons from weakly pathogenic mycobacteria and salmonellae
###end article-title 98
###begin article-title 99
Inherited disorders of IL-12- and IFNg-mediated immunity: A molecular genetics update
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human genetics of intracellular infectious diseases: Molecular and cellular immunity against mycobacteria and salmonellae
###end article-title 100
###begin article-title 101
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
###end article-title 101
###begin article-title 102
###xml 82 87 <span type="species:ncbi:9606">human</span>
Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures
###end article-title 102
###begin article-title 103
Single step method of RNA isolation by acid guanidinum phenol chloroform extraction
###end article-title 103
###begin article-title 104
Differential roles of interleukin-18 (IL-18) and IL-12 for induction of gamma interferon by staphylococcal cell wall components and superantigens
###end article-title 104
###begin article-title 105
Activation of interferon-g inducing factor mediated by interleukin-1beta converting enzyme
###end article-title 105
###begin article-title 106
Caspase-1 processes IFN-g-inducing factor and regulates LPS-induced IFN-g production
###end article-title 106
###begin article-title 107
Role of muramyl peptides for the enhancement of synthetic vaccines
###end article-title 107
###begin article-title 108
Regulation of interferon-gamma production by IL-12 and IL-18
###end article-title 108
###begin article-title 109
IL-18: A Th1-inducing, proinflammatory cytokine and a new member of the IL-1 family
###end article-title 109
###begin article-title 110
###xml 66 71 <span type="species:ncbi:9606">human</span>
Dissociation between interleukin-1b mRNA and protein synthesis in human peripheral blood mononuclear cells
###end article-title 110
###begin article-title 111
Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: Translational signal provided by lipopolysaccharide or IL-1 itself
###end article-title 111
###begin article-title 112
Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1b mRNA show unequal IL-1b protein accumulation but similar polyribosome profiles
###end article-title 112
###begin article-title 113
###xml 27 32 <span type="species:ncbi:9606">human</span>
Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell
###end article-title 113
###begin article-title 114
Biologic basis for interleukin-1 in disease
###end article-title 114
###begin article-title 115
Network communications: Lymphotoxins, LIGHT, and TNF
###end article-title 115
###begin article-title 116
IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity
###end article-title 116
###begin article-title 117
###xml 132 158 132 158 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 132 158 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection
###end article-title 117
###begin article-title 118
Nerve growth factor and fibroblast growth factor regulate neurite outgrowth and gene expression in PC12 cells via both protein kinase C- and cAMP-independent mechanisms
###end article-title 118
###begin article-title 119
###xml 57 83 57 83 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mycobacterium tuberculosis</named-content>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 57 83 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis
###end article-title 119
###begin title 120
Figures and Tables
###end title 120
###begin title 121
Stimulation of IL-32 by Mycobacteria
###end title 121
###begin p 122
###xml 82 97 81 96 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 107 115 106 114 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 82 97 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 99 102 <span type="species:ncbi:1773">MTB</span>
###xml 107 119 <span type="species:ncbi:33892">M. bovis BCG</span>
(A) Whole blood was diluted 1:4 with RPMI and stimulated with 10 mug/ml sonicated M. tuberculosis (MTB) or M. bovis BCG (BCG). Triton X-100 (0.5%) was added 24 h later, and IL-32 concentration was measured by ECL.
###end p 122
###begin p 123
###xml 90 105 90 105 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 90 105 <span type="species:ncbi:1773">M. tuberculosis</span>
(B) Stimulation of freshly isolated PBMCs with various concentrations of LPS or sonicated M. tuberculosis stimulated IL-32 synthesis in a dose-dependent manner.
###end p 123
###begin p 124
###xml 131 146 129 144 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 148 156 146 154 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 165 174 163 172 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">S. aureus</named-content>
###xml 189 190 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 265 282 263 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis&#8211;,</italic>
###xml 287 295 285 293 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 131 146 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 148 160 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 165 174 <span type="species:ncbi:1280">S. aureus</span>
###xml 265 280 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 287 299 <span type="species:ncbi:33892">M. bovis BCG</span>
(C and D) Freshly isolated PBMCs were stimulated with TLR4 (LPS, 100 ng/ml), TLR2 (Pam3Cys, 10 mug/ml), TLR3 (poly I:C, 5 mug/ml), M. tuberculosis, M. bovis BCG, or S. aureus (all at 1 x 107 microorganisms/milliliter, heat-killed). After 24 h of stimulation, LPS-, M. tuberculosis-, and M. bovis BCG-stimulated production of IL-32 (C) or IL-6 (D) was measured by ECL.
###end p 124
###begin p 125
###xml 37 40 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
Data are presented as means +/- SEM (n = 8).
###end p 125
###begin title 126
IL-32 Induced by Inflammatory Stimuli Is a Cell-Associated Cytokine
###end title 126
###begin p 127
###xml 57 72 56 71 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 144 151 143 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="st2">Methods</xref>
###xml 4 9 <span type="species:ncbi:9606">Human</span>
###xml 57 72 <span type="species:ncbi:1773">M. tuberculosis</span>
(A) Human PBMCs were stimulated with 10 mug/ml sonicated M. tuberculosis. After 24 h, supernatants and cell lysates were assayed for IL-32 (see Methods).
###end p 127
###begin p 128
###xml 162 177 162 177 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 162 177 <span type="species:ncbi:1773">M. tuberculosis</span>
(B) RT-PCR of the four IL-32 isoforms in freshly lysed PBMCs (lane1), PBMCs incubated in medium for 4 h (lane 2), stimulated with 100 ng/ml LPS (lane 3), or with M. tuberculosis (lane 4).
###end p 128
###begin title 129
###xml 59 74 59 74 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 24 29 <span type="species:ncbi:9606">Human</span>
###xml 59 74 <span type="species:ncbi:1773">M. tuberculosis</span>
IL-32 Immunostaining of Human PBMCs Stimulated with LPS or M. tuberculosis
###end title 129
###begin p 130
###xml 120 135 120 135 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 120 135 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 137 140 <span type="species:ncbi:1773">MTB</span>
(A) Freshly isolated PBMCs were left to adhere, stimulated with either control medium (first row), LPS (second row), or M. tuberculosis (MTB; third row), and 24 h later stained for the presence of IL-32. Nuclei were stained with AMCA (blue, left panels), and IL-32 was stained with Cy3 (red, middle panels). The right panels show the merged pictures with WGA-stained cellular surface (green).The stained cells were examined by digital deconvoluted microscopy.
###end p 130
###begin p 131
###xml 78 93 78 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 78 93 <span type="species:ncbi:1773">M. tuberculosis</span>
(B) PBMCs stimulated with control medium (left panel), LPS (middle panel), or M. tuberculosis (right panel) were stained with an anti-IL-32 monoclonal antibody and counterstained with Mayer's hematoxylin for optical microscopy.
###end p 131
###begin title 132
IL-32 Production by Monocytes, Macrophages, and DCs
###end title 132
###begin p 133
###xml 249 264 243 258 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 281 289 275 283 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 249 264 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 281 293 <span type="species:ncbi:33892">M. bovis BCG</span>
(A) PBMCs were incubated for 2 h at 37 degreesC in 96-well plates, and non-adherent lymphocytes were transferred to a different well. The total PBMCs, the adherent monocytes, or the non-adherent lymphocytes were stimulated with RPMI (hatched bars), M. tuberculosis (open bars), or M. bovis BCG (solid bars) for an additional 24 h. After 24 h, IL-32 concentrations were measured.
###end p 133
###begin p 134
###xml 286 301 286 301 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 318 326 318 326 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. bovis</named-content>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 286 301 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 318 330 <span type="species:ncbi:33892">M. bovis BCG</span>
(B) Adherent monocytes were incubated for 5 d with RPMI and 20% human serum for macrophage differentiation, or a combination of 50 ng/ml GM-CSF and 20 ng/ml IL-4 for DC differentiation. The macrophages and DCs were thereafter stimulated for an additional 24 h with RPMI (hatched bars), M. tuberculosis (open bars), or M. bovis BCG (solid bars). IL-32 concentration was measured by ECL.
###end p 134
###begin p 135
###xml 37 38 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 48 49 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 62 63 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data are presented as means +/- SEM (n = 8); *, p < 0.05; **, p < 0.01.
###end p 135
###begin title 136
IFNgamma Is a Stimulus of IL-32 Production
###end title 136
###begin p 137
(A) PBMCs isolated from five volunteers were stimulated with IFNgamma, IL-1beta, or TNFalpha (all at a concentration of 10 ng/ml). IL-32 concentrations were measured by ECL 24 h later in cells lysed with Triton X-100.
###end p 137
###begin p 138
###xml 46 61 46 61 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 72 87 72 87 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 46 61 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 63 66 <span type="species:ncbi:1773">MTB</span>
###xml 72 87 <span type="species:ncbi:1773">M. tuberculosis</span>
(B) PBMCs were stimulated for 24 h with RPMI, M. tuberculosis (MTB), or M. tuberculosis in combination with 10 mug/ml IL-18BP. IFNgamma and TNFalpha concentrations were measured 24 h later.
###end p 138
###begin p 139
###xml 37 40 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 48 49 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data are presented as means +/- SEM (n = 5); *, p < 0.05.
###end p 139
###begin title 140
###xml 0 15 0 15 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
M. tuberculosis Stimulates IL-32 through a Caspase-1/IL-18/IFNgamma-Dependent Mechanism
###end title 140
###begin p 141
###xml 33 48 33 48 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 76 91 76 91 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 557 572 542 557 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 683 698 668 683 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 767 782 752 767 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. tuberculosis</named-content>
###xml 832 835 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n =</italic>
###xml 843 844 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 33 48 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 50 53 <span type="species:ncbi:1773">MTB</span>
###xml 76 91 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 241 246 <span type="species:ncbi:9606">human</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
###xml 557 572 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 683 698 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 767 782 <span type="species:ncbi:1773">M. tuberculosis</span>
PBMCs were stimulated with RPMI, M. tuberculosis (MTB), or a combination of M. tuberculosis and cytokine inhibitors: 20 muM of a caspase-1 inhibitor (casp-1inh) (A), 10 mug/ml IL-18BP (B), IL-1Ra (C), or 10 mug/ml of a monoclonal mouse anti-human IFNgamma antibody (D). As a control for the anti-IFNgamma antibody, a similar concentration of a purified mouse IgG1 antibody was used in the control stimulation. After 24 h of incubation, IL-32, IFNgamma, and TNF concentrations were measured by ECL. The dashed line represents the 100% stimulation induced by M. tuberculosis alone. The open bars represent the unstimulated cells, and the solid bars represent the cells stimulated with M. tuberculosis in the presence of the cytokine inhibitors, expressed as percent of M. tuberculosis production. Data are presented as means +/- SEM (n = 8); *, p < 0.05.
###end p 141
###begin p 142
Primer Sequences Used in the RT-PCR for the Four Isoforms of IL-32
###end p 142

